ClinicalTrials.gg
Not yet recruitingNCT07943767CARE-DBS-FALLUpdated Nov 17, 2026

Caregiver-Based Fall Prevention Education in Patients Undergoing Awake Deep Brain Stimulation

An interventional study of AI-Supported Structured Fall Prevention Education in Parkinson Disease, Movement Disorders and Accidental Falls, sponsored by Halic University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Halic University · Not applicable, Interventional, and Prevention

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 172 studies in Parkinson Disease with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Parkinson Disease · Turkey.

Planned enrollment
4th of 99
128 · median 32
Started
2026
with 28 others
No phase
92 of 172
26 open now
Primary completion
2027-03
later than 50 of 55 live
Registered
172nd of 172
by date

Among the 172 studies in Parkinson Disease with a site in Turkey, this one is the 4th largest by planned enrollment of the 99 interventional ones that give a count, is one of 29 that started in 2026, is one of 92 with no phase, reaches primary completion later than 50 of the 55 other live ones, and was the 172nd registered.

Parkinson Disease

4,578 studies on the registry are indexed under Parkinson Disease; 1,085 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

50 of the 172 studies in Parkinson Disease with a site in Turkey are open now. Recruiting first, the newest first:

45 more — sign in →

All 50 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 748 Parkinson Disease studies recruiting now, 311 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 172 studies in Parkinson Disease with a site in Turkey, or all of them as a file.
02

Study summary

Awake deep brain stimulation (DBS) is an effective surgical treatment for Parkinson's disease and other movement disorders, but patients remain at high risk of falls after surgery because of gait disturbance, postural instability, cognitive decline and transient postoperative delirium. Primary caregivers are the people in closest contact with these patients before surgery and after discharge, yet no caregiver-based fall prevention approach specific to this group has been tested. This single-center, parallel-group randomized controlled trial aims to evaluate the effect of an AI-supported structured fall prevention education given to primary caregivers before surgery on caregivers' fall prevention behaviors and on patients' postoperative falls and near-falls. Sixty-four patient-primary caregiver dyads will be randomized 1:1 to education plus usual care or usual care alone. Caregiver behaviors will be observed from postoperative day 0 to day 7 (or until discharge) using a structured observation form.

Read the detailed description

This is a single-center, two-arm, parallel-group randomized controlled trial with a 1:1 allocation ratio, conducted at the Neurosurgery Clinic of Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. The unit of randomization is the patient-primary caregiver dyad; each patient and his/her primary caregiver are assigned to the same group, and only one primary caregiver is enrolled per patient.

Sample size was calculated with G*Power 3.1.9.7 based on a similar randomized controlled trial of caregiver fall prevention education (Wang, Zou \& Wang, 2022). Because the reported effect size was large (Cohen's d = 1.14), a more conservative d = 0.80 was used with two-sided alpha = 0.05, 80% power and 1:1 allocation, giving 26 dyads per group (52 in total). Allowing for 15% attrition (dropout, change of primary caregiver, missing observations), 32 dyads per group (64 dyads; 64 patients and 64 caregivers, 128 participants) will be enrolled.

Randomization: Dyads will be allocated by computer-generated block randomization (block size 4) by an independent researcher not involved in recruitment, education or data collection. Allocation concealment will be ensured with sequentially numbered, opaque, sealed envelopes prepared by the same independent researcher; the envelope is opened after written informed consent is obtained and the Patient and Primary Caregiver Descriptive Information Form is completed.

Intervention: In addition to routine clinical care, primary caregivers in the experimental group will receive AI-supported structured fall prevention education in the preoperative period. The content, prepared according to current fall prevention literature, covers safe support during first mobilization, bed-chair transfer, walking and toileting, control of environmental risks, and safe use of assistive walking devices. Education will be delivered face to face by the same researcher, with the same content and materials, in a room separate from patient rooms to minimize contamination between groups. The control group will receive routine clinical care only; for ethical reasons, the education content will be offered to control-group caregivers after data collection is completed.

Data collection: The Patient and Primary Caregiver Descriptive Information Form (26 items) will be completed by face-to-face interview before surgery. Caregivers' fall prevention behaviors will be assessed with the Caregiver Fall Prevention Behavior Observation Form (18 behaviors in 4 sections: first mobilization, bed-chair transfer, corridor walking, assistance with toileting and return; each scored 0-2; content validity assessed by 10 experts). First mobilization is observed on postoperative day 0, and the other three sections daily on postoperative days 1-7 (or until discharge if earlier). Falls and near-falls are recorded for each section and day. Observations are performed simultaneously and independently by two trained observers; if a fall risk arises during observation, observers intervene to ensure patient safety and the event is recorded as a near-fall.

Analysis: Data will be analyzed with IBM SPSS by an independent statistician blinded to group allocation, following the intention-to-treat principle, with 95% confidence intervals and p \< 0.05. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total divided by the number of observed behaviors; range 0-2) will be used, and its change over time will be analyzed with linear mixed-effects models (group, time and group-by-time interaction). Fall and near-fall counts will be analyzed with Poisson or, if needed, negative binomial regression. Inter-observer agreement will be assessed with weighted Cohen's kappa and intraclass correlation coefficient. Reporting will follow the CONSORT statement.

03

Conditions studied

  • Parkinson Disease
  • Movement Disorders
  • Accidental Falls
  • Deep Brain Stimulation

Keywords

  • awake deep brain stimulation
  • fall prevention
  • caregiver education
  • nursing
  • near-fall
  • patient safety
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients:

  • Aged 18 years or older
  • Scheduled for awake deep brain stimulation surgery
  • Able to communicate in Turkish
  • Having a primary caregiver who will accompany the patient during the hospital stay
  • Agreeing to participate in the study

Primary caregivers:

  • Aged 18 years or older
  • Being the patient's primary caregiver
  • Taking part in the patient's care and the planned observations during the postoperative hospital stay
  • Able to read and write in Turkish
  • Agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

Patients:

  • Need for prolonged intensive care after surgery
  • Development of a serious clinical complication preventing the planned mobilization and observations
  • Transfer to another institution before completion of the study
  • Request of the patient or legal representative to withdraw from the study

Primary caregivers:

  • Not completing the structured education program (experimental group)
  • Being unable to continue accompanying the patient in hospital
  • Change of the primary caregiver during the study
  • Request to withdraw from the study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Caregiver Fall Prevention Education

    Primary caregivers receive AI-supported structured fall prevention education, delivered face to face in the preoperative period, in addition to the clinic's routine care and information.

    Behavioral: AI-Supported Structured Fall Prevention Education

  • No intervention
    Usual Care

    Patient-caregiver dyads receive only the clinic's routine care and information. For ethical reasons, the education content will be offered to caregivers after data collection is completed.

Interventions

  • BehavioralAI-Supported Structured Fall Prevention Education

    Face-to-face structured education delivered by the same researcher to the primary caregiver before awake DBS surgery, using standardized AI-supported materials prepared according to current fall prevention literature. Content: safe support of the patient during first mobilization, bed-chair transfer, walking and toileting; control of environmental fall risks; and safe use of assistive walking devices. Education is given in a room separate from patient rooms.

06

What researchers measure

Primary outcomes

  1. Change in Mean Caregiver Fall Prevention Behavior Score

    Measured with the Caregiver Fall Prevention Behavior Observation Form developed by the researchers (18 behaviors in 4 sections: first mobilization \[5\], bed-chair transfer \[4\], corridor walking \[5\], assistance with toileting and return \[4\]). Each behavior is scored 0 = not performed/performed incorrectly, 1 = partially correct, 2 = fully correct; behaviors not observed or not required on a given day are coded as not observed and excluded. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total score divided by the number of observed behaviors; range 0-2) is used to assess change over time; higher scores indicate more accurate and complete fall prevention behaviors. Observations are made independently by two trained observers.

    Time frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

Secondary outcomes

  1. Number of Patient Falls During Postoperative Hospitalization

    Number and rate of patient falls observed during the postoperative hospital stay, recorded as yes/no for each observed activity and day on the Caregiver Fall Prevention Behavior Observation Form.

    Time frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

  2. Number of Near-Fall Events During Postoperative Hospitalization

    Number and rate of near-fall events (situations in which a fall risk arose and the observers intervened to ensure patient safety) during the postoperative hospital stay.

    Time frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

07

Study locations

1 site
  • Basaksehir Cam and Sakura City Hospital, Neurosurgery Clinic
    Istanbul, Basaksehir 34480, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared in order to protect participant confidentiality.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.

Of 1,295 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 4 months is below that.

Counting every sponsor, half of 1,371 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Mar 15, 2027
CompletionEst.
Mar 15, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943767
Lead sponsor
Halic University
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Mar 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Kübra Can
Contact
kubracan@halic.edu.tr
+90 543 871 17 95
Emine Güngör Turan, MSc, Specialist Nurse
principal investigator · Başakşehir Çam & Sakura City Hospital
Fatma Eti Aslan, Prof. Dr.
study chair · Bahçeşehir University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion